$33M sweet spot round size
Most of their 3 investments are in rounds between $12M and $33M
2002
CytoPherx, Inc. raised $12M on June 17, 2010
Investors: Diamond Capital Management
TransMolecular raised $33M on March 1, 2004
Investors: TVM Life Science Management Inc, Greer Capital Advisors, Oakwood Medical Center, Tullis Health Investors, Pacific Horizon Ventures, MSD Partners, L.P., Easton Capital Investment Group and Diamond Capital Management
NeurogesX, Inc. raised $35M on February 24, 2004
Investors: Montreux Equity Partners, TIAA, ARCH Venture Partners, Alta Partners, University of North Carolina at Chapel Hill and Diamond Capital Management